Roivant director granted 5,054 RSUs, 10,531 options
Roivant director Keith S. Manchester received time-based RSUs and stock options that fully vest in 2027 as part of non-employee director compensation.
Rhea-AI Filing Summary
Roivant Sciences Ltd. (ROIV) reported that director Keith S. Manchester received equity compensation on September 16, 2026. He was granted 5,054 Common Shares in the form of restricted stock units and stock options for 10,531 Common Shares at an exercise price of $39.57 per share.
Both the RSUs and options are scheduled to vest 100% on September 16, 2027, subject to his continued service as a director. After the RSU grant, he directly holds 1,753,457 Common Shares. The options expire on September 15, 2036, and no Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 15,585 shares
Grant/Award
2 txns
Insider
MANCHESTER KEITH S
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F2 | 10,531 | $0.00 | $0.00 |
| Grant/Award | Common Shares F1 | 5,054 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 10,531 contracts (Direct);
Common Shares — 1,753,457 shares (Direct)
Footnotes (2)
- F1. Reflects an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 16, 2027, subject generally to the reporting person's service as a director through such date.
- F2. Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 16, 2027, subject generally to the reporting person's service as a director through such date.
Key Figures
RSUs granted: 5,054 shares
Stock options granted: 10,531 options
Option exercise price: $39.57 per share
+3 more
6 metrics
RSUs granted
5,054 shares
Annual restricted stock unit award on September 16, 2026
Stock options granted
10,531 options
Annual option award on September 16, 2026
Option exercise price
$39.57 per share
Exercise price for options to purchase Common Shares
Post-grant common share holdings
1,753,457 shares
Common Shares directly held after RSU grant
Vesting date
September 16, 2027
RSUs and options vest 100% on this date, subject to service
Option expiration date
September 15, 2036
Expiration of stock options granted
Key Terms
restricted stock units, Equity Incentive Plan, Non-Employee Director Compensation Policy, stock options
4 terms
restricted stock units financial
"Reflects an annual award of restricted stock units with respect to Common Shares"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Equity Incentive Plan financial
"granted pursuant to the Company's 2021 Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
Non-Employee Director Compensation Policy financial
"and the Company's Non-Employee Director Compensation Policy"
stock options financial
"Reflects an annual award of stock options to purchase Common Shares"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Roivant Sciences (ROIV) grant to director Keith S. Manchester?
Roivant granted Keith S. Manchester 5,054 RSUs settling in Common Shares and stock options for 10,531 Common Shares at an exercise price of $39.57 per share on September 16, 2026, under the 2021 Equity Incentive Plan and Non-Employee Director Compensation Policy.
When do the new RSUs and stock options for ROIV’s director vest?
Both the 5,054 RSUs and 10,531 stock options granted to Roivant director Keith S. Manchester are scheduled to vest and become fully exercisable 100% on September 16, 2027, subject generally to his continued service as a director through that date.
What is the exercise price and expiration date of the new Roivant (ROIV) stock options?
The stock options granted to Keith S. Manchester have an exercise price of $39.57 per Common Share and are scheduled to expire on September 15, 2036, according to the company’s non-employee director compensation arrangements.
Are Keith S. Manchester’s ROIV equity grants under a Rule 10b5-1 trading plan?
No. The Form 4 indicates that the Rule 10b5-1 checkbox is not checked, and the footnotes describe these awards as annual equity grants under Roivant’s 2021 Equity Incentive Plan and Non-Employee Director Compensation Policy.
AI-generated analysis. How Rhea-AI works. Not financial advice.
